Proof of Usefulness Report

Strat2tact Consulting

Analysis completed on 2/13/2026

+115
Proof of Usefulness Score
Gaining Momentum

The project 'Strat2tact Consulting' is a legitimate boutique consulting firm for the biopharma industry, not a technology product. While the founder, Jovan Antunovic, has verifiable industry experience (25+ years), the submission fails critical PoU criteria for a tech evaluation. The input data contains significantly exaggerated or false claims (e.g., 'audience reach: everyone', 'most people have used my product') and lacks any technical innovation. The 'marketcap: 500000' likely refers to revenue or valuation but is ambiguous. As a service-based business with no scalable technology component and poor submission data quality, it scores in the minimal traction range for this framework.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+75
Audience Reach Impact+5
Technical Innovation+0
Evidence Of Traction+12.5
Market Timing Relevance+40
Functional Completeness+2.5
Subtotal+135
Usefulness Multiplierx0.85
Final Score+115

Project Details

Project URL
strat2tact.com
Description
🌟 GLOBAL HEALTHCARE LEADER | 25+ YEARS OF TRANSFORMATIONAL IMPACT 🌟 Fluent in English and French, I bring 25+ years of leadership across 15+ therapeutic areas in the U.S., Canada, and Europe. From navigating complex reimbursement landscapes to leading global, regional, and country-level operations, I specialize in turning challenges into commercial success. 🚀 PROVEN RESULTS IN: ✅ Launching & scaling biotech, pharma, and medtech businesses. ✅ Building and revitalizing high-performing teams. ✅ Developing and executing winning commercialization strategies in complex markets. 🎯 STRAT2TACT CONSULTING – Fractional Commercial Leadership for Biopharma, BIotech, Med Devices and Medtech ***BETTER DECISIONS. BETTER OUTCOMES*** At STRAT2TACT, we help companies bridge the gap between strategy and execution, providing fractional commercialization leadership and hands-on expertise in: ✅ Go-to-Market Strategy – From launch planning to market access & sales execution ✅ Fractional Leadership – Acting as an interim executive or commercial lead ✅ VC & BD Support – Due diligence, asset evaluation, and growth strategy We deliver results across: Marketing | Sales | Market Access | Patient Support | Medical Affairs | Regulatory | Procurement | HR | Legal, and more. With deep expertise in biopharma, biotech, medtech, and medical devices, we create tailored strategies to drive growth, access, and impact. 📍 Learn more: www.strat2tact.com 🌍 GEOGRAPHIC & THERAPEUTIC EXPERTISE 🗺️ United States | Canada | Europe | Japan 💊 15+ therapeutic areas, including Oncology, Cardiology, Immunology, and more. 💡 PHILOSOPHY: "Insanity is doing the same thing over and over and expecting different results." – Albert Einstein Let’s innovate, execute, and redefine healthcare commercialization together. 🚀

Algorithm Insights

Market Position
Growing utility with room for optimization
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline